EUVIMED · CrossrefZeitschrift
Current Opinion in Oncology
ISSN 1040-8746 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma
Recent highlights and breakthroughs in immunotherapy for head and neck cancers
Circulating Epstein–Barr virus DNA as a precision biomarker in nasopharyngeal carcinoma: from risk stratification to real-time treatment adaptation and disease surveillance
Circulating tumor DNA for human papilloma virus-positive disease: ready for prime time?
Steady progress in the treatment of advanced prostate cancer: a year in review
Antibody-drug conjugates: new drugs – new toxicities
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma
Immunotherapy in rare histologies of breast cancer: challenges, opportunities, and future perspectives
Open questions on vorasidenib
Liquid biopsy in breast cancer: promises and challenges
Which sarcoma requires PD1/PDL1 inhibitors, and what should be the best scheme? Present status and next steps
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy
Polyamine metabolism in prostate cancer
Peripheral neuropathy: from guidelines to clinical practise
The role of the microbiome in skin cancer development and treatment
Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments
Implementation of sentinel node biopsy in high-risk endometrial cancer
Update of antibody–drug conjugates for hematological malignancies
Potential application of artificial intelligence in cancer therapy
Emerging therapies in Ewing sarcoma
Active surveillance and emerging medical treatment options for desmoid: when and for whom?
Advances in testing for human papillomavirus-mediated head and neck cancer
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence
Pathologic diagnosis of lung cancer – recent developments
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer
Unveiling the enigma of the blood–brain barrier in glioblastoma: current advances from preclinical and clinical studies
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics
Machine learning applications and challenges in graft-versus-host disease: a scoping review
Jahrgänge
2026 · 472025 · 942024 · 902023 · 872022 · 1072021 · 1002020 · 962019 · 942018 · 702017 · 742016 · 822015 · 882014 · 1042013 · 1102012 · 1212011 · 1142010 · 1052009 · 1102008 · 1052007 · 1092006 · 1012005 · 992004 · 952003 · 612002 · 862001 · 922000 · 991999 · 951998 · 1111997 · 1091996 · 1071995 · 1341994 · 1181993 · 1161992 · 1651991 · 1191990 · 2111989 · 34
EUVIMED